###begin article-title 0
###xml 27 31 <span type="species:ncbi:10090">Mice</span>
Quadrupling Muscle Mass in Mice by Targeting TGF-ss Signaling Pathways
###end article-title 0
###begin p 1
Conceived and designed the experiments: SL. Performed the experiments: SL. Analyzed the data: SL. Contributed reagents/materials/analysis tools: SL. Wrote the paper: SL.
###end p 1
###begin p 2
###xml 865 868 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 861 868 860 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1153 1157 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 111 115 <span type="species:ncbi:10090">Mice</span>
###xml 262 268 <span type="species:ncbi:9913">cattle</span>
###xml 270 275 <span type="species:ncbi:9940">sheep</span>
###xml 277 281 <span type="species:ncbi:9615">dogs</span>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 496 501 <span type="species:ncbi:9606">human</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
Myostatin is a transforming growth factor-ss family member that normally acts to limit skeletal muscle growth. Mice genetically engineered to lack myostatin activity have about twice the amount of muscle mass throughout the body, and similar effects are seen in cattle, sheep, dogs, and a human with naturally occurring loss-of-function mutations in the myostatin gene. Hence, there is considerable interest in developing agents capable of inhibiting myostatin activity for both agricultural and human therapeutic applications. We previously showed that the myostatin binding protein, follistatin, can induce dramatic increases in muscle mass when overexpressed as a transgene in mice. In order to determine whether this effect of follistatin results solely from inhibition of myostatin activity, I analyzed the effect of this transgene in myostatin-null mice. Mstn-/- mice carrying a follistatin transgene had about four times the muscle mass of wild type mice, demonstrating the existence of other regulators of muscle mass with similar activity to myostatin. The greatest effect on muscle mass was observed in offspring of mothers homozygous for the Mstn mutation, raising the possibility that either myostatin itself or a downstream regulator may normally be transferred from the maternal to fetal circulations. These findings demonstrate that the capacity for increasing muscle growth by manipulating TGF-ss signaling pathways is much more extensive than previously appreciated and suggest that muscle mass may be controlled at least in part by a systemic mode of action of myostatin.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 137 140 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee1">[1]</xref>
###xml 185 189 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 334 337 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-McPherron1">[2]</xref>
###xml 428 432 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 438 441 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Grobet1">[3]</xref>
###xml 443 446 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Welle1">[4]</xref>
###xml 531 534 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Whittemore1">[5]</xref>
###xml 535 538 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee2">[7]</xref>
###xml 968 971 966 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Grobet2">[8]</xref>
###xml 972 976 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Grobet3">[11]</xref>
###xml 985 989 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Clop1">[12]</xref>
###xml 996 1000 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Mosher1">[13]</xref>
###xml 1012 1016 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Schuelke1">[14]</xref>
###xml 1321 1325 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Bogdanovich1">[15]</xref>
###xml 1326 1330 1324 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Bogdanovich2">[17]</xref>
###xml 1440 1444 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-McPherron3">[18]</xref>
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 961 967 <span type="species:ncbi:9913">cattle</span>
###xml 979 984 <span type="species:ncbi:9940">sheep</span>
###xml 991 995 <span type="species:ncbi:9615">dogs</span>
###xml 1005 1011 <span type="species:ncbi:9606">humans</span>
###xml 1316 1320 <span type="species:ncbi:10090">mice</span>
###xml 1395 1400 <span type="species:ncbi:10090">mouse</span>
Myostatin (MSTN) is a transforming growth factor-ss (TGF-ss) family member that plays a critical role in regulating skeletal muscle mass [1]. Mice engineered to carry a deletion of the Mstn gene have about a doubling of skeletal muscle mass throughout the body as a result of a combination of muscle fiber hyperplasia and hypertrophy [2]. Moreover, loss of myostatin activity resulting either from postnatal inactivation of the Mstn gene [3], [4] or following administration of various myostatin inhibitors to wild type adult mice [5]-[7] can also lead to significant muscle growth. Hence, myostatin appears to play as least two distinct roles, one to regulate the number of muscle fibers that are formed during development and a second to regulate growth of muscle fibers postnatally. The function of myostatin appears to have been conserved across species, as inactivating mutations in the myostatin gene have been demonstrated to cause increased muscling in cattle [8]-[11] , sheep [12], dogs [13] and humans [14]. As a result, there has been considerable effort directed at developing strategies to modulate myostatin activity in clinical settings where enhancing muscle growth may be beneficial. In this regard, loss of myostatin activity has been demonstrated to improve muscle mass and function in dystrophic mice [15]-[17] and to have beneficial effects on fat and glucose metabolism in mouse models of obesity and type II diabetes [18].
###end p 4
###begin p 5
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Wolfman1">[6]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee3">[19]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Thies1">[20]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Zimmers1">[21]</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Hill1">[22]</xref>
###xml 534 542 534 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee3">[19]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Zimmers1">[21]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Hill1">[22]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Hill2">[23]</xref>
###xml 678 685 678 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Zimmers1">[21]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee3">[19]</xref>
###xml 805 814 <span type="species:ncbi:10090">nude mice</span>
###xml 829 844 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
Myostatin is synthesized as a precursor protein that undergoes proteolytic processing to generate an N-terminal propeptide and a C-terminal dimer, which is the biologically active species. Following proteolytic processing, the propeptide remains bound to the C-terminal dimer and maintains it in an inactive, latent complex [6], [19], [20], which represents one of the major forms of myostatin that circulates in the blood [21], [22]. In addition to the propeptide, other binding proteins are capable of regulating myostatin activity in vitro, including follistatin [19], [21], FLRG [22], and Gasp-1 [23]. We previously showed that follistatin can also block myostatin activity in vivo; specifically, we showed that follistatin can ameliorate the cachexia induced by high level expression of myostatin in nude mice [21] and that transgenic mice expressing follistatin in muscle have dramatic increases in muscle mass [19]. Here, I show that overexpression of follistatin can also cause substantial muscle growth in mice lacking myostatin, demonstrating that other TGF-ss related ligands normally cooperate with myostatin to suppress muscle growth and that the capacity for enhancing muscle growth by targeting this signaling pathway is much larger than previously appreciated.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
###xml 25 40 <span type="species:ncbi:10090">transgenic mice</span>
Increased muscle mass in transgenic mice expressing FLRG
###end title 7
###begin p 8
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Hill1">[22]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Hill2">[23]</xref>
###xml 257 265 257 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 967 975 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000789-g001">Figure 1</xref>
###xml 1098 1105 1098 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t001">Table 1</xref>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
###xml 1563 1567 <span type="species:ncbi:10090">mice</span>
Previous studies have identified several proteins that are normally found in a complex with myostatin in the blood [22], [23]. One of these is the follistatin related protein, FLRG, which has been demonstrated to be capable of inhibiting myostatin activity in vitro. To determine whether FLRG can also inhibit myostatin activity in vivo, I generated a construct in which the FLRG coding sequence was placed downstream of a myosin light chain promoter/enhancer. From pronuclear injections of this construct, a total of four transgenic mouse lines (Z111A, Z111B, Z116A, and Z116B) were obtained containing independently segregating insertion sites. Each of these four transgenic lines was backcrossed at least 6 times to C57 BL/6 mice prior to analysis in order to control for genetic background effects. Northern analysis revealed that in three of these lines the transgene was expressed in skeletal muscles but not in any of the non-skeletal muscle tissues examined (Figure 1); in the fourth line, Z111B, the expression of the transgene was below the level of detection in these blots. As shown in Table 1, all four lines exhibited significant increases in muscle weights compared to wild type control mice. These increases were observed in all four muscles that were examined as well as in both sexes. Moreover, the rank order of magnitude of these increases correlated with the rank order of expression levels of the transgene; in the highest-expressing line, Z116A, muscle weights were increased by 57-81% in females and 87-116% in males compared to wild type mice. Hence, FLRG is capable of increasing muscle growth in a dose-dependent manner when expressed as a transgene in skeletal muscle.
###end p 8
###begin title 9
###xml 26 41 <span type="species:ncbi:10090">transgenic mice</span>
Northern analysis of FLRG transgenic mice.
###end title 9
###begin p 10
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Total RNA was prepared from various tissues from 10-week old female mice, electrophoresed, blotted, and probed with a fragment derived from SV40 corresponding to the processing/polyadenylation sequences present in the transgenic construct. The blots were re-hybridized with a probe for the S26 ribosomal protein to control for loading.
###end p 10
###begin title 11
###xml 54 69 <span type="species:ncbi:10090">transgenic mice</span>
Muscle weights (mg) of FLRG (Z) and follistatin (F66) transgenic mice.
###end title 11
###begin p 12
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 1,
###end p 12
###begin p 13
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 1,
###end p 13
###begin p 14
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 1,
###end p 14
###begin p 15
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 3,
###end p 15
###begin p 16
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 3,
###end p 16
###begin p 17
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 9,
###end p 17
###begin p 18
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 9,
###end p 18
###begin p 19
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 9,
###end p 19
###begin p 20
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 16,
###end p 20
###begin p 21
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 17,
###end p 21
###begin p 22
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 18,
###end p 22
###begin p 23
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 18,
###end p 23
###begin p 24
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 20,
###end p 24
###begin p 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 20,
###end p 25
###begin p 26
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 11
###end p 26
###begin p 27
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t001">Table 1</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000789-g002">Figure 2a</xref>
###xml 802 805 802 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 798 805 798 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1026 1033 1026 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 427 442 <span type="species:ncbi:10090">transgenic mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 925 940 <span type="species:ncbi:10090">transgenic mice</span>
To determine whether the FLRG transgene was causing increased muscle growth by blocking myostatin activity, I examined the effect of combining the FLRG transgene with a loss-of-function mutation in the myostatin gene. To date, using the Z116A line, I have not been able to generate mice that are both positive for the transgene and homozygous for the myostatin deletion mutation. However, I did obtain a number of female Z116A transgenic mice that were heterozygous for the myostatin mutation, and as shown in Table 1 and Figure 2a, these mice exhibited further increases in muscle weights compared to Z116A mice that were wild type for myostatin. Most importantly, in two of the muscles that were examined (quadriceps and gastrocnemius) the observed increases were also greater than those seen in Mstn-/- mice lacking the transgene. Based on this finding, it appears that myostatin cannot be the sole target for FLRG in the transgenic mice and, therefore, that additional ligands must be capable of suppressing muscle growth in vivo.
###end p 27
###begin title 28
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z116A</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
###xml 109 124 <span type="species:ncbi:10090">transgenic mice</span>
Muscle weight increases in (A) female Mstn mutant and Z116A transgenic mice and (B) male Mstn mutant and F66 transgenic mice.
###end title 28
###begin p 29
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t001">Table 1</xref>
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 263 266 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 255 266 255 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66/Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
Numbers represent percent increases relative to wild type mice and were calculated from the data shown in Table 1. (C) Distribution of fiber diameters. Gray bars represent muscles from wild type mice, and red bars represent muscles from Mstn-/-, F66, and F66/Mstn-/- mice.
###end p 29
###begin title 30
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Effect of follistatin in Mstn null mice
###end title 30
###begin p 31
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee3">[19]</xref>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 892 895 892 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 950 953 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 958 961 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 954 961 954 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 1000 1003 1000 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 996 1003 996 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 1011 1014 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1007 1014 1007 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1036 1043 1036 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t001">Table 1</xref>
###xml 1072 1076 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 1116 1119 1116 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1185 1188 1185 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1229 1233 1229 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 1270 1273 1270 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1278 1281 1278 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1274 1281 1274 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1293 1296 1293 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1289 1296 1289 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1339 1342 1339 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1335 1342 1335 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1360 1363 1360 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1419 1422 1419 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1427 1430 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1423 1430 1423 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1498 1508 1498 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000789-g002">Figures 2b</xref>
###xml 1513 1514 1513 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000789-g003">3</xref>
###xml 1544 1547 1544 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1567 1570 1567 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1563 1570 1563 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 309 324 <span type="species:ncbi:10090">transgenic mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 896 911 <span type="species:ncbi:10090">transgenic mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 1189 1204 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1297 1301 <span type="species:ncbi:10090">mice</span>
###xml 1343 1347 <span type="species:ncbi:10090">mice</span>
###xml 1431 1435 <span type="species:ncbi:10090">mice</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
###xml 1642 1646 <span type="species:ncbi:10090">mice</span>
Because I was unable to examine the effect of overexpressing FLRG in the complete absence of myostatin, it was difficult to ascertain the relative importance of these additional ligands compared to myostatin in regulating muscle mass. However, I carried out a similar set of experiments utilizing follistatin transgenic mice, which demonstrated that these additional ligands do play a major role in suppressing muscle growth. In previous studies, we had generated several transgenic founders expressing follistatin from a myosin light chain promoter/enhancer [19]. I was able to establish a transgenic line from one of these founders (F66), and I backcrossed this line extensively to C57 BL/6 mice for subsequent analysis. In this line, the transgene was most likely located on the Y chromosome, as the transgene was transmitted to all of the male offspring and none of the female offspring. F66 transgenic mice were mated with Mstn mutant mice, and F66/Mstn+/- males were then mated with either Mstn+/- or Mstn-/- females. As shown in Table 1, the presence of one or two Mstn mutant alleles in combination with the F66 transgene resulted in increasingly more muscle mass than seen in F66 transgenic mice that were wild type for Mstn. Moreover, muscle weights in either F66/Mstn+/- or F66/Mstn-/- mice were dramatically higher than in Mstn-/- mice lacking the F66 transgene. In the most extreme case, muscle weights in F66/Mstn-/- mice were increased by 250-350% from those seen in wild type mice (Figures 2b and 3). Hence, the presence of the F66 transgene in a Mstn-/- background caused yet another doubling of muscle weights, resulting in mice with approximately quadruple the normal amount of muscle. These findings demonstrate that like FLRG, follistatin must be exerting its effect on muscle growth by targeting other ligands in addition to myostatin and that the effect of blocking these other ligands is comparable in magnitude to that resulting from loss of myostatin.
###end p 31
###begin title 32
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 39 28 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66/Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Comparison of wild type and F66/Mstn-/- mice.
###end title 32
###begin p 33
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-McPherron1">[2]</xref>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t002">Table 2</xref>
###xml 379 388 379 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000789-g002">Figure 2c</xref>
###xml 491 494 491 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 678 681 678 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 674 681 674 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 905 908 905 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 901 908 901 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 950 953 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1211 1214 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1247 1251 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 1354 1357 1354 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 1362 1365 1362 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1358 1365 1358 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1560 1564 1560 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 954 969 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1366 1370 <span type="species:ncbi:10090">mice</span>
###xml 1570 1574 <span type="species:ncbi:10090">mice</span>
In previous studies, we showed that the increase in muscle mass in Mstn-/- mice results from a combination of increased fiber numbers and increased fiber sizes [2]. To determine whether the same is true for the additional muscle mass seen upon introduction of the F66 transgene, I carried out morphometric analysis of the gastrocnemius/plantaris muscles. As shown in Table 2 and Figure 2c, total fiber number and mean fiber diameter were increased by about 48% and 19%, respectively, in Mstn-/- mice compared to wild type mice. As the cross-sectional area of the muscle would be expected to be roughly proportional to the square of the diameter, increased fiber diameter in Mstn-/- mice would correspond to an approximately 43% increase in fiber mass. Hence, muscle fiber hyperplasia and hypertrophy appear to contribute roughly equally to give the overall doubling of gastrocnemius/plantaris mass in Mstn-/- mice. In contrast, a similar analysis of F66 transgenic mice revealed that although total fiber number was increased slightly (16%), the overall increase in gastrocnemius/plantaris mass resulted almost entirely from muscle fiber hypertrophy (93% increase in cross-sectional area). In mice in which the F66 transgene was combined with the Mstn null mutation, the two phenotypes appeared to be additive; that is, the quadrupling of muscle mass in F66/Mstn-/- mice resulted from an approximately 73% increase in fiber number and 117% increase in fiber cross-sectional area. These results suggest that the additional muscle mass induced by follistatin in Mstn null mice results from inhibition of additional ligands that act predominantly to regulate muscle fiber growth.
###end p 33
###begin title 34
Morphometric analysis of gastrocnemius/plantaris muscles.
###end title 34
###begin p 35
calculated as relative fiber diameter squared,
###end p 35
###begin p 36
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+/+</sup></italic>
###xml 15 18 15 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>+/+</sup></italic></bold>
p<0.05 vs. Mstn+/+,
###end p 36
###begin p 37
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+/+</sup></italic>
###xml 16 19 16 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>+/+</sup></italic></bold>
p<0.001 vs. Mstn+/+
###end p 37
###begin title 38
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
Maternal effect of the Mstn null mutation
###end title 38
###begin p 39
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t001">Table 1</xref>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/+</sup></italic>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 443 450 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/+</sup></italic>
###xml 534 537 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 530 537 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/+</sup></italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 580 587 580 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 621 628 621 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 671 674 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 667 674 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 712 715 712 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 708 715 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 768 771 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 776 779 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 772 779 772 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 816 819 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 28 43 <span type="species:ncbi:10090">transgenic mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
In the experiments with F66 transgenic mice, a consistent finding was that muscle weights were higher in animals of the same genotype if they arose from crosses in which the mother had fewer functional Mstn alleles (Table 1). This maternal effect was observed to some extent in all of the muscles examined but was most pronounced in the quadriceps and gastrocnemius. For example, muscle weights of F66/Mstn+/+ males obtained from crosses with Mstn+/- females were higher than those of F66/Mstn+/+ males obtained from crosses with Mstn+/+ females. Similarly, muscle weights of F66/Mstn+/- males obtained from crosses with Mstn-/- females were higher than those of F66/Mstn+/- males obtained from crosses with Mstn+/- females. The most dramatic effects were observed in F66/Mstn-/- mice obtained from crosses with Mstn-/- females, in which muscle weights were approximately quadrupled compared to wild type mice.
###end p 39
###begin p 40
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t003">Table 3</xref>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 465 468 465 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 461 468 461 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 507 510 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/+</sup></italic>
###xml 526 529 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 593 600 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/&#8722;</sup></italic>
###xml 639 642 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 635 642 635 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 654 661 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>+/+</sup></italic>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
To determine whether this maternal effect was specific to the presence of the F66 transgene, I carried out a variety of crosses of Mstn mutant mice lacking the transgene. As shown in Table 3, the maternal effect on muscle weights was observed in these crosses as well. In virtually every case, mice with identical genotypes exhibited higher muscle weights if the mother had fewer functional Mstn alleles. The most clear cut results were obtained in analyses of Mstn+/- offspring derived from crosses of Mstn+/+ males with Mstn-/- females, which showed significantly higher muscle weights than Mstn+/- offspring derived from crosses of Mstn-/- males with Mstn+/+ females. Hence, the maternal effect on muscle mass was not dependent on the presence of the F66 transgene.
###end p 40
###begin title 41
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
Maternal effect of Mstn null mutation.
###end title 41
###begin p 42
Numbers represent muscle weights (mg).
###end p 42
###begin p 43
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 1,
###end p 43
###begin p 44
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 3,
###end p 44
###begin p 45
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 3,
###end p 45
###begin p 46
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 3,
###end p 46
###begin p 47
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 6,
###end p 47
###begin p 48
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 8,
###end p 48
###begin p 49
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. line 10,
###end p 49
###begin p 50
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. line 10,
###end p 50
###begin p 51
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. line 10
###end p 51
###begin p 52
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Ji1">[24]</xref>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 758 764 758 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 849 853 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 920 927 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000789-t004">Table 4</xref>
###xml 321 325 <span type="species:ncbi:9823">pigs</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
Conceivably, this maternal effect could result from transfer of myostatin or a downstream mediator either prenatally from the maternal to fetal circulations or postnatally from the mother to the offspring during nursing; in this respect, myostatin mRNA has been reported to be expressed in the mammary gland of lactating pigs [24]. To distinguish these two possibilities, I analyzed the effect of transferring neonates obtained from crosses with mothers of one Mstn genotype to foster mothers of a different Mstn genotype. In these experiments, all transfers were carried out using neonatal mice less than 24 hours old to mothers that had delivered their own litters also within the previous 24 hours. In order to control for effects of the transfer process per se, I also carried out transfers of neonates obtained from crosses with mothers of one Mstn genotype to foster mothers of the same Mstn genotype. As shown in Table 4, mice of a given genotype and parentage exhibited comparable muscle weights regardless of the genotype of the foster mothers. Hence, if there is a mediator of muscle mass that is transferred through the milk, I was not able to detect any resultant effects on muscle mass in these experiments. Taken together, these results suggest that the maternal effect on muscle mass results most likely from prenatal transfer of some mediator from mother to fetus, perhaps myostatin itself.
###end p 52
###begin title 53
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Muscle weights (mg) following transfer of newborn mice to foster mothers.
###end title 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
Based on the data presented here, two important conclusions can be drawn. The first is that the Mstn loss-of-function mutation exerts a maternal effect such that muscle mass of the fetus is influenced by the number of functional Mstn alleles in the mother. Specifically, I show that offspring with identical Mstn genotypes have higher muscle weights if the mother has fewer functional Mstn alleles. This finding taken together with the results of cross fostering experiments suggest that muscle mass can be influenced by prenatal transfer of some mediator from mother to fetus; although myostatin itself is the most obvious candidate for this mediator, additional experiments will be required to prove this definitively.
###end p 55
###begin p 56
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Zimmers1">[21]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Bullough1">[25]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Bullough2">[26]</xref>
###xml 1362 1365 1362 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee1">[1]</xref>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
We showed previously that myostatin circulates in the blood and that systemic effects can be achieved by implanting myostatin-expressing cells into a single site in the lower limb [21]; however, there have been no experiments that have demonstrated conclusively that myostatin normally acts systemically. The demonstration that maternal effects can be seen in offspring of mice lacking myostatin is consistent with the possibility that the circulating myostatin protein can enter the active pool. If myostatin does act systemically, the implication would be that local control of muscle growth can be influenced at least in part by myostatin being produced elsewhere in the body and that myostatin functions precisely as a chalone, as originally hypothesized by Bullough [25], [26] for the control for tissue growth in general. This is a critical issue, as it relates to the fundamental reason that the control of muscle growth may have evolved into this rather complex regulatory system. In this respect, I speculated previously that perhaps the myostatin regulatory system may serve two distinct functions, one to regulate local growth of muscle in response to specific physiological stimuli, such as injury, and a second to regulate the overall metabolic balance between fat and muscle in response to general physiological stimuli, such as nutritional status [1]. According to this model, local control of muscle growth would be achieved by regulating the extent to which the latent form of myostatin is activated at the target site, whereas global control of the metabolic homeostatic balance between muscle and other tissues would be achieved by regulating the size of the circulating pool of myostatin.
###end p 56
###begin p 57
###xml 1156 1159 1155 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Lee2">[7]</xref>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
The second important finding presented here is the demonstration that other ligands work with myostatin to control muscle growth. I have presented data showing that FLRG, like follistatin, can promote muscle growth when expressed as a transgene in skeletal muscle and that both of these molecules appear to act by blocking not only myostatin but also other ligands with similar activity to myostatin. By combining the follistatin transgene with a myostatin null mutation, I have been able to generate mice with quadrupled muscle mass, which represents yet another doubling of muscle mass compared to mice only lacking myostatin. These studies demonstrate that muscle mass in mice is controlled by multiple members of the transforming growth factor-ss superfamily acting in concert. We reached a similar conclusion in an earlier study in which we demonstrated that administration of a soluble form of the ACVR2B receptor to wild type could cause more extensive muscle growth than what had been observed previously using myostatin-specific inhibitors and that this soluble receptor could also increase muscle growth even in mice completely lacking myostatin [7]. The studies presented here demonstrate that the capacity for promoting muscle growth by targeting this general signaling pathway is far greater than previously appreciated.
###end p 57
###begin p 58
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Schuelke1">[14]</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000789-Zimmers1">[21]</xref>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 567 573 <span type="species:ncbi:9606">humans</span>
###xml 656 662 <span type="species:ncbi:9606">humans</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 872 878 <span type="species:ncbi:9606">humans</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 1145 1150 <span type="species:ncbi:9606">human</span>
Because myostatin normally acts to limit muscle growth, there has been considerable interest in targeting this pathway to attempt to enhance muscle growth in human patients with muscle wasting and muscle degenerative diseases. Most efforts in this regard have focused on agents capable of binding specifically to myostatin and inhibiting its activity. The finding that myostatin is not the sole regulator of muscle mass in mice raises the question as to whether targeting myostatin alone will be the most effective strategy for manipulating this signaling pathway in humans. In this respect, it is known that the circulating levels of myostatin protein in humans are considerably lower than in mice [14], [21], raising the possibility that the balance of the relative roles played by myostatin and by these other regulators may have shifted further away from myostatin in humans compared to mice. For these reasons, it will be essential to determine the identity of the other ligand or ligands that cooperate with myostatin, as only then will we be able to develop the best possible strategies for manipulating this pathway for the treatment of human diseases in which promoting muscle growth may be beneficial.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin p 60
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F66</italic>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
Pronuclear injections of DNA and embryo transfers were carried out by the Johns Hopkins Transgenic Core Facility. Mstn mutant and F66 and FLRG transgenic mice were backcrossed at least 6 times onto a C57 BL/6 background prior to analysis. All analysis was carried out on 10 week old mice. For measurement of muscle weights, individual muscles from both sides of the animal were dissected, and the average weight was used for each muscle. For morphometric analysis, the gastrocnemius and plantaris muscles were sectioned serially to their widest point using a cryostat, and fiber diameters were measured (as the shortest distance across the fiber passing through the midpoint) from hematoxylin and eosin stained sections. Measurements were carried out on 250 fibers per animal, and all data for a given genotype were pooled.
###end p 60
###begin p 61
###xml 224 228 <span type="species:ncbi:10090">mice</span>
I thank Kunihiro Tsuchida for providing the FLRG cDNA clone, the Johns Hopkins Transgenic Core Facility for carrying out the pronuclear injections and embryo transfers, and Will Kirk and Jay VanRensselaer for photography of mice.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Regulation of muscle mass by myostatin.
###end article-title 63
###begin article-title 64
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Regulation of skeletal muscle mass in mice by a new TGF-ss superfamily member.
###end article-title 64
###begin article-title 65
Modulating skeletal muscle mass by postnatal, muscle-specific inactivation gene.
###end article-title 65
###begin article-title 66
Muscle growth after postdevelopmental myostatin gene knockout.
###end article-title 66
###begin article-title 67
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.
###end article-title 67
###begin article-title 68
Activation of latent myostatin by the BMP-1/tolloid family of metaloproteinases.
###end article-title 68
###begin article-title 69
Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
###end article-title 69
###begin article-title 70
###xml 18 24 <span type="species:ncbi:9913">bovine</span>
###xml 79 85 <span type="species:ncbi:9913">cattle</span>
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle.
###end article-title 70
###begin article-title 71
###xml 77 83 <span type="species:ncbi:9913">cattle</span>
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle.
###end article-title 71
###begin article-title 72
###xml 19 25 <span type="species:ncbi:9913">cattle</span>
Double muscling in cattle due to mutations in the myostatin gene.
###end article-title 72
###begin article-title 73
###xml 120 126 <span type="species:ncbi:9913">cattle</span>
Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle.
###end article-title 73
###begin article-title 74
###xml 111 116 <span type="species:ncbi:9940">sheep</span>
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.
###end article-title 74
###begin article-title 75
###xml 103 107 <span type="species:ncbi:9615">dogs</span>
A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs.
###end article-title 75
###begin article-title 76
###xml 65 70 <span type="species:ncbi:9606">child</span>
Myostatin mutation associated with gross muscle hypertrophy in a child.
###end article-title 76
###begin article-title 77
Functional improvement of dystrophic muscle by myostatin blockade.
###end article-title 77
###begin article-title 78
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
###end article-title 78
###begin article-title 79
Myostatin propeptide-mediated ameliortion of dystophic pathophysiology.
###end article-title 79
###begin article-title 80
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Suppression of body fat accumulation in myostatin-deficient mice.
###end article-title 80
###begin article-title 81
Regulation of myostatin activity and muscle growth.
###end article-title 81
###begin article-title 82
GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding.
###end article-title 82
###begin article-title 83
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Induction of cachexia in mice by systemically administered myostatin.
###end article-title 83
###begin article-title 84
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum.
###end article-title 84
###begin article-title 85
Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.
###end article-title 85
###begin article-title 86
Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation.
###end article-title 86
###begin article-title 87
The control of mitotic activity in adult mammalian tissues.
###end article-title 87
###begin article-title 88
Mitotic and functional homeostasis: A speculative review.
###end article-title 88
###begin p 89
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Myostatin was licensed by the Johns Hopkins University to MetaMorphix (MMI) and sublicensed to Wyeth. The author is entitled to a share of sales royalty received by the University from sales of this factor. The Johns Hopkins University and the author also own MMI stock, which is subject to certain restrictions under University policy. The author is a paid consultant to MMI and to Merck. The terms of these arrangements are being managed by the University in accordance with its conflict of interest policies.
###end p 89
###begin p 90
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Institutes of Health (R01HD35887 and U54AR052646), a grant from the Muscular Dystrophy Association (MDA3765), and a gift from Merck Research Laboratories.
###end p 90

